Morphotek Revenue and Competitors
Estimated Revenue & Valuation
- Morphotek's estimated annual revenue is currently $16.1M per year.
- Morphotek's estimated revenue per employee is $155,000
Employee Data
- Morphotek has 104 Employees.
- Morphotek grew their employee count by -3% last year.
Morphotek's People
Name | Title | Email/Phone |
---|---|---|
1 | Director IT | Reveal Email/Phone |
2 | Manager | Reveal Email/Phone |
3 | Manager, Quality Systems | Reveal Email/Phone |
4 | Senior Scientist | Reveal Email/Phone |
5 | Senior Quality Control Specialist at Morphotek | Reveal Email/Phone |
Morphotek Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 9 | -10% | N/A | N/A |
#2 | $7.1M | 46 | 77% | N/A | N/A |
#3 | $14.4M | 93 | 27% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $1.6M | 10 | 43% | N/A | N/A |
#6 | $11.5M | 74 | 6% | N/A | N/A |
#7 | $0.9M | 11 | 22% | N/A | N/A |
#8 | $3.7M | 24 | -8% | N/A | N/A |
#9 | $2M | 13 | 18% | N/A | N/A |
#10 | $9.3M | 60 | 2% | N/A | N/A |
What Is Morphotek?
Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies.
keywords:N/AN/A
Total Funding
104
Number of Employees
$16.1M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 108 | 5% | N/A |
#2 | $16.1M | 111 | -7% | N/A |
#3 | $7.5M | 152 | 5% | N/A |
#4 | $32.3M | 163 | 47% | N/A |
#5 | $31.4M | 164 | 34% | N/A |